The trading price of Health In Tech Inc (NASDAQ:HIT) closed higher on Tuesday, March 25, and closing at $0.77, 20.31% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.6156 and $0.8181. The company’s P/E ratio in the trailing 12-month period was 62.10. In examining the 52-week price action we see that the stock hit a 52-week high of $7.59 and a 52-week low of $0.59. Over the past month, the stock has lost -88.49% in value.
Health In Tech Inc, whose market valuation is $9.01 million at the time of this writing, is expected to release its quarterly earnings report in April. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
A quick review shows that HIT’s price is currently -80.65% off the SMA20 and -84.87% off the SMA50. The RSI metric on the 14-day chart is currently showing 20.44, and weekly volatility stands at 17.89%. When measured over the past 30 days, the indicator reaches 44.24%. Health In Tech Inc (NASDAQ:HIT)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 0.55.
To see how Health In Tech Inc stock has been performing in comparison to its peers in the industry, here are the numbers: HIT stock’s performance was 20.31% in the latest trading. Health In Tech Inc has a P/E ratio of 62.10.
An evaluation of the daily trading volume of Health In Tech Inc (NASDAQ:HIT) indicates that the 3-month average is 1.93 million. However, this figure has increased over the past 10 days to an average of 5.27.
Currently, records show that 42.91 million of the company’s shares remain outstanding. The insiders hold 85.54% of outstanding shares, whereasinstitutions hold 0.01%. The stats also highlight that short interest as of 2025-02-28, stood at 0.12 million shares, resulting in a short ratio of 0.07 at that time. From this, we can conclude that short interest is 97.00 of the company’s total outstanding shares. It is noteworthy that short shares in February were up slightly from the previous month’s figure, which was 17143.0. However, since the stock’s price has seen -85.62% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
